Which do we choose to carry forward?

  • There are a lot of drugs that are showing potential efficacy in docking studies. What criterion of the drug would you suggest to choose to carry forward investigations?

    Those docking studies are “directional,” and we need to take the compounds screened there forward into relevant cell lines. Caco2, Vero6, etc.

  • You must be logged in to reply to this topic.